Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity

It is well recognized that type II Diabetes (T2D) and overweight/obesity are established risk factors for stroke, worsening also their consequences. However, the underlying mechanisms by which these disorders aggravate outcomes are not yet clear limiting the therapeutic opportunities. To fill this g...

Full description

Saved in:
Bibliographic Details
Main Authors: Julien Clain, David Couret, Matthieu Bringart, Olivier Meilhac, Christian Lefebvre d’Hellencourt, Nicolas Diotel
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:IBRO Neuroscience Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667242124001106
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850103163807334400
author Julien Clain
David Couret
Matthieu Bringart
Olivier Meilhac
Christian Lefebvre d’Hellencourt
Nicolas Diotel
author_facet Julien Clain
David Couret
Matthieu Bringart
Olivier Meilhac
Christian Lefebvre d’Hellencourt
Nicolas Diotel
author_sort Julien Clain
collection DOAJ
description It is well recognized that type II Diabetes (T2D) and overweight/obesity are established risk factors for stroke, worsening also their consequences. However, the underlying mechanisms by which these disorders aggravate outcomes are not yet clear limiting the therapeutic opportunities. To fill this gap, we characterized, for the first time, the effects of T2D and obesity on the brain repair mechanisms occurring 7 days after stroke, notably glial scarring. In the present study, by performing a 30-minute middle cerebral artery occlusion (MCAO) on db/db (obese diabetics mice) and db/+ (controls) mice, we demonstrated that obese and diabetic mice displayed larger lesions (i.e. increased infarct volume, ischemic core, apoptotic cell number) and worsened neurological outcomes compared to their control littermates. We then investigated the formation of the glial scar in control and db/db mice 7 days post-stroke. Our observations argue in favor of a stronger and more persistent activation of astrocytes and microglia in db/db mice. Furthermore, an increased deposition of extracellular matrix (ECM) was observed in db/db vs control mice (i.e. chondroitin sulfate proteoglycan and collagen type IV). Consequently, we demonstrated for the first time that the db/db status is associated with increased astrocytic and microglial activation 7 days after stroke and resulted in higher deposition of ECM within the damaged area. Interestingly, the injury-induced neurogenesis appeared stronger in db/db as shown by the labeling of migrating neuroblast. This increase appeared correlated to the larger size of lesion. It nevertheless raises the question of the functional integration of the new neurons in db/db mice given the observed dense ECM, known to be repulsive for neuronal migration. Carefully limiting glial scar formation after stroke represents a promising area of research for reducing neuronal loss and limiting disability in diabetic/obese patients.
format Article
id doaj-art-2d52c59065e6418b975b8b3fb02de752
institution DOAJ
issn 2667-2421
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series IBRO Neuroscience Reports
spelling doaj-art-2d52c59065e6418b975b8b3fb02de7522025-08-20T02:39:37ZengElsevierIBRO Neuroscience Reports2667-24212025-06-0118163010.1016/j.ibneur.2024.12.002Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesityJulien Clain0David Couret1Matthieu Bringart2Olivier Meilhac3Christian Lefebvre d’Hellencourt4Nicolas Diotel5Université de la Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), Saint-Pierre 97410, FranceUniversité de la Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), Saint-Pierre 97410, France; CHU de La Réunion, Saint-Pierre 97410, FranceUniversité de la Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), Saint-Pierre 97410, FranceUniversité de la Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), Saint-Pierre 97410, France; CHU de La Réunion, Saint-Pierre 97410, FranceUniversité de la Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), Saint-Pierre 97410, France; Correspondence to: Laboratory DéTROI - Inserm U1188 - Université de La Réunion - Campus Santé, Diabète athérothrombose Thérapies Réunion Océan Indien 77 Avenue du Docteur Jean-Marie Dambreville, Saint-Pierre, Réunion 97410, France.Université de la Réunion, INSERM, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), Saint-Pierre 97410, France; Correspondence to: Laboratory DéTROI - Inserm U1188 - Université de La Réunion - Campus Santé, Diabète athérothrombose Thérapies Réunion Océan Indien 77 Avenue du Docteur Jean-Marie Dambreville, Saint-Pierre, Réunion 97410, France.It is well recognized that type II Diabetes (T2D) and overweight/obesity are established risk factors for stroke, worsening also their consequences. However, the underlying mechanisms by which these disorders aggravate outcomes are not yet clear limiting the therapeutic opportunities. To fill this gap, we characterized, for the first time, the effects of T2D and obesity on the brain repair mechanisms occurring 7 days after stroke, notably glial scarring. In the present study, by performing a 30-minute middle cerebral artery occlusion (MCAO) on db/db (obese diabetics mice) and db/+ (controls) mice, we demonstrated that obese and diabetic mice displayed larger lesions (i.e. increased infarct volume, ischemic core, apoptotic cell number) and worsened neurological outcomes compared to their control littermates. We then investigated the formation of the glial scar in control and db/db mice 7 days post-stroke. Our observations argue in favor of a stronger and more persistent activation of astrocytes and microglia in db/db mice. Furthermore, an increased deposition of extracellular matrix (ECM) was observed in db/db vs control mice (i.e. chondroitin sulfate proteoglycan and collagen type IV). Consequently, we demonstrated for the first time that the db/db status is associated with increased astrocytic and microglial activation 7 days after stroke and resulted in higher deposition of ECM within the damaged area. Interestingly, the injury-induced neurogenesis appeared stronger in db/db as shown by the labeling of migrating neuroblast. This increase appeared correlated to the larger size of lesion. It nevertheless raises the question of the functional integration of the new neurons in db/db mice given the observed dense ECM, known to be repulsive for neuronal migration. Carefully limiting glial scar formation after stroke represents a promising area of research for reducing neuronal loss and limiting disability in diabetic/obese patients.http://www.sciencedirect.com/science/article/pii/S2667242124001106astrogliosisCSPGMCAOdb/db miceextracellular matrixglial scar
spellingShingle Julien Clain
David Couret
Matthieu Bringart
Olivier Meilhac
Christian Lefebvre d’Hellencourt
Nicolas Diotel
Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity
IBRO Neuroscience Reports
astrogliosis
CSPG
MCAO
db/db mice
extracellular matrix
glial scar
title Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity
title_full Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity
title_fullStr Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity
title_full_unstemmed Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity
title_short Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity
title_sort effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity
topic astrogliosis
CSPG
MCAO
db/db mice
extracellular matrix
glial scar
url http://www.sciencedirect.com/science/article/pii/S2667242124001106
work_keys_str_mv AT julienclain effectofmetabolicdisordersonreactivegliosisandglialscarringattheearlysubacutephaseofstrokeinamousemodelofdiabetesandobesity
AT davidcouret effectofmetabolicdisordersonreactivegliosisandglialscarringattheearlysubacutephaseofstrokeinamousemodelofdiabetesandobesity
AT matthieubringart effectofmetabolicdisordersonreactivegliosisandglialscarringattheearlysubacutephaseofstrokeinamousemodelofdiabetesandobesity
AT oliviermeilhac effectofmetabolicdisordersonreactivegliosisandglialscarringattheearlysubacutephaseofstrokeinamousemodelofdiabetesandobesity
AT christianlefebvredhellencourt effectofmetabolicdisordersonreactivegliosisandglialscarringattheearlysubacutephaseofstrokeinamousemodelofdiabetesandobesity
AT nicolasdiotel effectofmetabolicdisordersonreactivegliosisandglialscarringattheearlysubacutephaseofstrokeinamousemodelofdiabetesandobesity